Get Premium

Get Premium

Dominate Financial Markets with Stock Target Advisor Premium Features

Analyst Ratings
Analyst Ratings

Daily targets and ratings from professional analysts
- LATEST ANALYST RATINGS
- Latest Analyst Ratings
- Top Analysts Screener
- Analyst Directory
- My Analysts
- LATEST RATINGS BY COUNTRY
- Canada
- USA
- UK
- India
- France
- Germany
Best Stocks
Best Stocks

Quickly zoom in on the stocks with highest and lowest potential based on analyst recommendations and Stock Target Advisor's own analysis
- Automatic Selection
- Top Stocks
- Worst Stocks
- Best Penny Stocks
- Best Performing Stocks
- Worst Performing Stocks
- Best Stocks Filters
- All Countries
- Canada
- USA
- UK
- India
- France
- Germany
Smart Screens
Smart Screens

Search stocks using 100s of variables and make your own screens
- Search
- Stock Screener
- Advanced Stock Search
- Industries
- Prebuilt Screens
- Popular Screens
- Cryptocurrency Stocks
- Canadian SPACs
- US SPACs
- High Dividend Stocks
- Low Cost Global Equity ETFs
- Reputable Companies
Watchlists & Portfolios
Watchlists & Portfolios

Track and analyze your holdings and favorite stocks
- My Watchlists
- My Portfolios
News & Calendars
News & Calendars

Stay on top of what’s happening in all markets
Insights
Insights

Latest research and insights from our analysts and users
Crowd Ratings
Crowd Ratings

Targets and analysis from users like you
Pricing
About Us

Adagio Therapeutics Inc Stock Analysis and Price Target COMMON STOCK | Biotechnology | NYE

Submit your target Discuss Add to watchlist

Take a Tour

N/A

Average Analyst
Rating

Slightly Bearish

Stock Target Advisor
Analysis

N/A

Average User
Rating

Last Closing Price

USD 3.48

Change

0.00 (0.00)%

Market Cap

USD 0.50B

Volume

0.27M

Avg User Target

N/A

ADGI

Adagio Therapeutics Inc (USD)

COMMON STOCK | NYE

USD 3.48

0.00 0

Take a Tour

Target Discuss Watchlist

Discussions

New Post

No discussions yet.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What not to like

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Symbol: ADGI:NYE

What is your target rating?*

Sell

Hold

Buy

What is your target price?*

USD

What is your Time Horizon for the Target Price ( between 0 - 11 months) ?*

- +

Share your analysis

1000 characters left

Get our Premium Service free for 7-days!

Link watchlist to your brokerage
Premium Newsletter
Daily Analyst Ratings
Detailed Stock Analysis
Top Picks
Watchlists and Portfolios
Advanced Screens
Detailed Reports
Donwloadable Data

Join over half-million smart investors across the world

Select Market

I agree to Stock Target Adivsor Terms and Conditions

or Sign up with

ADGI Adagio Therapeutics Inc